Aspects of emergency vaccination against foot-and-mouth disease

被引:18
作者
Barnett, P
Garland, AJM
Kitching, RP
Schermbrucker, CG
机构
[1] AFRC, Inst Anim Hlth, Pirbright Lab, Woking GU24 0NF, Surrey, England
[2] Collingwood, Surrey GU24 0JB, England
[3] Natl Ctr Foreign Anim Dis, Winnipeg, MB R3E 3M4, Canada
[4] Diani, Surrey GU10 1LB, England
关键词
foot-and-mouth disease; vaccination; emergency vaccination; vaccine banks;
D O I
10.1016/S0147-9571(02)00031-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Emergency vaccination is one of several measures which may be deployed to control outbreaks of foot-and-mouth disease. It can be a valuable adjunct to the application of the essential zoosanitary controls which must include rapid diagnosis, tracing, movement control and disinfection and which may also include slaughter of infected and in-contact animals and their safe disposal. Criteria which determine the successful application of emergency vaccination include access to vaccine(s) that (i) contain virus strain(s) of sufficient antigenic relatedness to the outbreak strain(s) (ii) are of the required type of vaccine formulation (iii) have acceptable innocuity and potency (iv) have appropriate availability, including quantity and immediacy of supply and (v) meet considerations of cost. Contingency planning should include provision for emergency vaccination and must address the complex decisions of not only when, where, and how to apply vaccine but also its economic consequences. Computer modelling may be a useful aid to cost benefit and decision support systems in this context. Planning must be detailed and regularly reviewed and should ensure, (i) that the legal and financial aspects are catered for (ii) that any contractual supply agreements are in place (iii) that information is collected and its currency maintained on the species, numbers and whereabouts of susceptible livestock (iv) that vaccination teams are formed and trained (v) that the vaccine cold chain is established and maintained (vi) that supplies of vaccination equipment are held in readiness and (vii) that briefing materials are available to inform the various stakeholders on relevant aspects of emergency vaccination. Knowledge concerning the characteristics and performance of emergency vaccines is summarised and areas identified for further research. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:345 / 364
页数:20
相关论文
共 43 条
[1]
IN-VITRO METHOD FOR SAFETY TESTING OF FOOT-AND-MOUTH DISEASE VACCINES [J].
ANDERSON, EC ;
CAPSTICK, PB ;
MOWAT, GN ;
LEECH, FB .
JOURNAL OF HYGIENE-CAMBRIDGE, 1970, 68 (02) :159-&
[2]
INACTIVATION OF VIRAL-ANTIGENS FOR VACCINE PREPARATION WITH PARTICULAR REFERENCE TO THE APPLICATION OF BINARY ETHYLENIMINE [J].
BAHNEMANN, HG .
VACCINE, 1990, 8 (04) :299-303
[3]
The suitability of the 'emergency' foot-and-mouth disease antigens held by the International Vaccine Bank within a global context [J].
Barnett, PV ;
Samuel, AR ;
Statham, RJ .
VACCINE, 2001, 19 (15-16) :2107-2117
[4]
International bank for foot-and-mouth disease vaccine: Assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants [J].
Barnett, PV ;
Pullen, L ;
Williams, L ;
Doel, TR .
VACCINE, 1996, 14 (13) :1187-1198
[5]
BARNETT PV, 1995, 31 SESS EUR COMM CON, P60
[6]
BARTELING SJ, 1997, FOOT MOUTH DIS VACCI, P68
[7]
BARTELING SJ, 1996, SESS RES GROUP STAND, P68
[8]
Brown F, 1999, ARCH VIROL, P179
[9]
Cox S. J., 2000, LONGEVITY ANTIBODY R, P247
[10]
Cox S. J., 1998, SESS RES GROUP STAND, P139